|
TMEM64 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.030600E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.992400E-01 |
| Normal-vs-Stage2 |
4.267800E-01 |
| Normal-vs-Stage3 |
7.403000E-01 |
| Normal-vs-Stage4 |
9.861600E-03 |
| Stage1-vs-Stage2 |
4.423000E-01 |
| Stage1-vs-Stage3 |
7.746200E-01 |
| Stage1-vs-Stage4 |
7.356300E-03 |
| Stage2-vs-Stage3 |
5.748200E-01 |
| Stage2-vs-Stage4 |
1.467230E-01 |
| Stage3-vs-Stage4 |
1.500370E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.163200E-01 |
| Normal-vs-AfricanAmerican |
1.895020E-01 |
| Normal-vs-Asian |
2.941200E-01 |
| Caucasian-vs-AfricanAmerican |
1.696650E-01 |
| Caucasian-vs-Asian |
4.996200E-01 |
| AfricanAmerican-vs-Asian |
1.480170E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.855400E-01 |
| Normal-vs-Female |
6.975000E-01 |
| Male-vs-Female |
7.653200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.036560E-01 |
| Normal-vs-Age(41-60Yrs) |
8.004200E-01 |
| Normal-vs-Age(61-80Yrs) |
5.117600E-01 |
| Normal-vs-Age(81-100Yrs) |
9.728800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.839810E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.631600E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.571000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.638600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.731600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.498800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
2.761400E-01 |
| Normal-vs-Grade 2 |
2.259600E-01 |
| Normal-vs-Grade 3 |
4.454800E-01 |
| Normal-vs-Grade 4 |
2.521200E-03 |
| Grade 1-vs-Grade 2 |
5.914000E-01 |
| Grade 1-vs-Grade 3 |
2.105600E-01 |
| Grade 1-vs-Grade 4 |
5.754400E-02 |
| Grade 2-vs-Grade 3 |
1.123150E-01 |
| Grade 2-vs-Grade 4 |
2.744500E-03 |
| Grade 3-vs-Grade 4 |
2.315600E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.361560E-01 |
| Normal-vs-ccB subtype |
9.925800E-01 |
| ccA subtype-vs-ccB subtype |
4.605800E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.899200E-01 |
| Normal-vs-N1 |
7.571700E-02 |
| N0-vs-N1 |
6.641500E-02 |
|
|
